Status:
UNKNOWN
Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer
Lead Sponsor:
UMC Utrecht
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Pancreatic cancer has a very poor survival, due to late diagnosis and lack of sufficient treatment options for locally advanced tumors and metastasized patients. High dose radiotherapy with small marg...
Detailed Description
Objective of the study: To determine safety and technical feasibility of stereotactic radiotherapy for locally advanced pancreatic carcinoma Study design: Pilot study to determine safety and feasib...
Eligibility Criteria
Inclusion
- Locally advanced pancreatic tumors (stage III) or medically inoperable patients with pancreatic cancer (stage I, II, or III)
- Not eligible for operation with curative intent
- \>18 years
- Written informed consent
Exclusion
- WHO performance status 3-4
- Expected life span \<3 months
- Previous chemotherapy, pancreatic surgery or pancreatic radiotherapy
- Exclusion criteria for contrast enhanced MRI and/or CT scan, following the protocol of the department of radiology UMCU
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01898741
Start Date
July 1 2013
End Date
July 1 2016
Last Update
February 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands, 3584 CX